Goldman Sachs Group Inc. Raises Stock Holdings in RELX PLC $RELX

Key Points

• Goldman Sachs Group Inc. increased its stake in RELX PLC by 4.5%, acquiring an additional 173,976 shares, bringing its total holdings to 4,072,342 shares valued at $205.3 million.
• RELX recently announced a semi-annual dividend of $0.2634 per share, which results in a yield of 170.0% and reflects a payout ratio of 28.49%.
• Shares of RELX have seen a 4.3% decline recently and currently sit near their 52-week low of $44.19, with analysts giving an average rating of "Buy" despite a recent downgrade by Wall Street Zen.

Goldman Sachs Group Inc. boosted its position in shares of RELX PLC (NYSE:RELX - Free Report) by 4.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,072,342 shares of the technology company's stock after buying an additional 173,976 shares during the period. Goldman Sachs Group Inc. owned 0.22% of RELX worth $205,287,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in RELX. BNP Paribas Financial Markets increased its position in RELX by 9.3% during the fourth quarter. BNP Paribas Financial Markets now owns 46,198 shares of the technology company's stock worth $2,098,000 after buying an additional 3,917 shares during the period. Baird Financial Group Inc. acquired a new position in shares of RELX in the fourth quarter valued at approximately $623,000. Cetera Investment Advisers increased its holdings in shares of RELX by 8.6% in the fourth quarter. Cetera Investment Advisers now owns 55,460 shares of the technology company's stock valued at $2,519,000 after purchasing an additional 4,369 shares during the period. Focus Partners Wealth increased its holdings in shares of RELX by 84.9% in the fourth quarter. Focus Partners Wealth now owns 10,235 shares of the technology company's stock valued at $471,000 after purchasing an additional 4,701 shares during the period. Finally, Pathstone Holdings LLC increased its holdings in shares of RELX by 0.8% in the fourth quarter. Pathstone Holdings LLC now owns 186,999 shares of the technology company's stock valued at $8,493,000 after purchasing an additional 1,433 shares during the period. Institutional investors and hedge funds own 15.02% of the company's stock.

RELX Price Performance

RELX traded down $0.18 during trading on Tuesday, reaching $46.68. 1,059,818 shares of the stock were exchanged, compared to its average volume of 1,541,294. The business's 50 day moving average price is $49.53 and its two-hundred day moving average price is $51.09. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The company has a market capitalization of $85.55 billion, a price-to-earnings ratio of 25.10, a P/E/G ratio of 3.06 and a beta of 0.87. RELX PLC has a 1 year low of $44.19 and a 1 year high of $56.33.

RELX Cuts Dividend

The company also recently announced a semi-annual dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th will be given a dividend of $0.2634 per share. This represents a yield of 170.0%. The ex-dividend date is Friday, August 8th. RELX's payout ratio is presently 28.49%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on RELX shares. Morgan Stanley reissued an "overweight" rating on shares of RELX in a report on Thursday, September 11th. Wall Street Zen lowered RELX from a "buy" rating to a "hold" rating in a report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the stock. According to data from MarketBeat.com, RELX currently has an average rating of "Buy".

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.